Plasma RNA integrity analysis: Methodology and validation

Annals of the New York Academy of Sciences

Volumn 1075, Issue , 2006, Pages 174-178

  Wong, Blenda C K ^a   Lo, Y M Dennis ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Integrity; Plasma RNA; Quantitative analysis

Indexed keywords

RNA;

BLOOD LEVEL; CELL FREE SYSTEM; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; DNA TRANSCRIPTION; HUMAN; METHODOLOGY; QUANTITATIVE ANALYSIS; RNA ANALYSIS; RNA STABILITY; VALIDITY;

EID: 33749563843     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1368.023     Document Type: Conference Paper

References (13)

1. LO, Y.M.D. 2001. Circulating nucleic acids in plasma and serum: an overview. Ann. N. Y. Acad. Sci. 945: 1-7.
2. LO, K.W. et al. 1999. Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma. Clin. Chem. 45: 1292-1294.
3. KOPRESKI, M.S. et al. 1999. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin. Cancer Res. 5: 1961-1965.
4. DASI, F.S. et al. 2001. Real-time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA: a simple blood test to monitor disease in cancer patients. Lab. Invest. 81: 767-769.
5. WONG, S.C. et al. 2004. Quantification of plasma beta-catenin mRNA in colorectal cancer and adenoma patients. Clin. Cancer Res. 10: 1613-1617.
6. POON, L.L.M. et al. 2000. Presence of fetal RNA in maternal plasma. Clin. Chem. 46: 1832-1834.
7. NG, E.K.O. et al. 2003. mRNA of placental origin is readily detectable in maternal plasma. Proc. Natl. Acad. Sci. USA 100: 4748-4753.
8. NG, E.K.O. et al. 2004. Evaluation of human chorionic gonadotropin beta-subunit mRNA concentrations in maternal serum in aneuploid pregnancies: a feasibility study. Clin. Chem. 50: 1055-1057.
9. TSUI, N.B.Y. et al. 2002. Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin. Chem. 48: 1647-1653.
10. HALICKA, H.D. et al. 2000. Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis. Exp. Cell Res. 260: 248-256.
11. NG, E.K.O. et al. 2002. Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin. Chem. 48: 1212-1217.
12. WONG, B.C.K. et al. 2005. Circulating placental RNA in maternal plasma is associated with a preponderance of 5 mRNA fragments: implications for noninvasive prenatal diagnosis and monitoring. Clin. Chem. 51: 1786-1795.
13. BUSTIN, S.A. 2000. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 25: 169-193.